231 related articles for article (PubMed ID: 16537700)
1. The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women.
dos Santos Silva I; Johnson N; De Stavola B; Torres-Mejía G; Fletcher O; Allen DS; Allen NE; Key TJ; Fentiman IS; Holly JM; Peto J
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):449-55. PubMed ID: 16537700
[TBL] [Abstract][Full Text] [Related]
2. Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.
Rinaldi S; Biessy C; Hernandez M; Lesueur F; dos-Santos-Silva I; Rice MS; Lajous M; Lopez-Ridaura R; Torres-Mejía G; Romieu I
Int J Cancer; 2014 Mar; 134(6):1436-44. PubMed ID: 24037648
[TBL] [Abstract][Full Text] [Related]
3. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density.
Byrne C; Colditz GA; Willett WC; Speizer FE; Pollak M; Hankinson SE
Cancer Res; 2000 Jul; 60(14):3744-8. PubMed ID: 10919644
[TBL] [Abstract][Full Text] [Related]
4. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density.
Lai JH; Vesprini D; Zhang W; Yaffe MJ; Pollak M; Narod SA
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):573-82. PubMed ID: 15066922
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density.
Diorio C; Pollak M; Byrne C; Mâsse B; Hébert-Croteau N; Yaffe M; Coté G; Bérubé S; Morin C; Brisson J
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1065-73. PubMed ID: 15894654
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies.
Rice MS; Tworoger SS; Rosner BA; Pollak MN; Hankinson SE; Tamimi RM
Breast Cancer Res Treat; 2012 Dec; 136(3):805-12. PubMed ID: 23085768
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
8. Possible effects of insulin-like growth factor-I, IGF-binding protein-3 and IGF-1/IGFBP-3 molar ratio on mammographic density: a cross-sectional study.
Meggiorini ML; Cipolla V; Borgoni G; Nofroni I; Pala A; de Felice C
Eur J Gynaecol Oncol; 2012; 33(1):74-8. PubMed ID: 22439410
[TBL] [Abstract][Full Text] [Related]
9. Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density.
Taverne CW; Verheus M; McKay JD; Kaaks R; Canzian F; Grobbee DE; Peeters PH; van Gils CH
Breast Cancer Res Treat; 2010 Oct; 123(3):843-55. PubMed ID: 20155489
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I (IGF-1), IGF-binding protein-3 (IGFBP-3) and mammographic features.
Izzo L; Meggiorini ML; Nofroni I; Pala A; De Felice C; Meloni P; Simari T; Izzo S; Pugliese F; Impara L; Merlini G; Di Cello P; Cipolla V; Forcione AR; Paliotta A; Domenici L; Bolognese A
G Chir; 2012 May; 33(5):153-62. PubMed ID: 22709450
[TBL] [Abstract][Full Text] [Related]
11. Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.
Horne HN; Sherman ME; Pfeiffer RM; Figueroa JD; Khodr ZG; Falk RT; Pollak M; Patel DA; Palakal MM; Linville L; Papathomas D; Geller B; Vacek PM; Weaver DL; Chicoine R; Shepherd J; Mahmoudzadeh AP; Wang J; Fan B; Malkov S; Herschorn S; Hewitt SM; Brinton LA; Gierach GL
Breast Cancer Res; 2016 Feb; 18(1):24. PubMed ID: 26893016
[TBL] [Abstract][Full Text] [Related]
12. Relationship of circulating insulin-like growth factor-I and binding proteins 1-7 with mammographic density among women undergoing image-guided diagnostic breast biopsy.
Hada M; Oh H; Pfeiffer RM; Falk RT; Fan S; Mullooly M; Pollak M; Geller B; Vacek PM; Weaver D; Shepherd J; Wang J; Fan B; Mahmoudzadeh AP; Malkov S; Herschorn S; Brinton LA; Sherman ME; Gierach GL
Breast Cancer Res; 2019 Jul; 21(1):81. PubMed ID: 31337427
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk.
Allen NE; Roddam AW; Allen DS; Fentiman IS; Dos Santos Silva I; Peto J; Holly JM; Key TJ
Br J Cancer; 2005 Apr; 92(7):1283-7. PubMed ID: 15756268
[TBL] [Abstract][Full Text] [Related]
15. IGF-I and mammographic density in four geographic locations: a pooled analysis.
Maskarinec G; Takata Y; Chen Z; Gram IT; Nagata C; Pagano I; Hayashi K; Arendell L; Skeie G; Rinaldi S; Kaaks R
Int J Cancer; 2007 Oct; 121(8):1786-92. PubMed ID: 17520679
[TBL] [Abstract][Full Text] [Related]
16. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
[TBL] [Abstract][Full Text] [Related]
17. Intact and total insulin-like growth factor-binding protein-3 (IGFBP-3) levels in relation to breast cancer risk factors: a cross-sectional study.
Diorio C; Brisson J; Bérubé S; Pollak M
Breast Cancer Res; 2008; 10(3):R42. PubMed ID: 18471292
[TBL] [Abstract][Full Text] [Related]
18. Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest.
Rollison DE; Giuliano AR; Risendal BC; Sweeney C; Boulware D; Laronga C; Baumgartner KB; Byers T; Slattery ML
Breast Cancer Res Treat; 2010 Jun; 121(3):661-9. PubMed ID: 19888649
[TBL] [Abstract][Full Text] [Related]
19. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer.
Rollison DE; Newschaffer CJ; Tao Y; Pollak M; Helzlsouer KJ
Int J Cancer; 2006 Mar; 118(5):1279-84. PubMed ID: 16161053
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal changes in IGF-I and IGFBP-3, and mammographic density among postmenopausal women.
Woolcott CG; Courneya KS; Boyd NF; Yaffe MJ; McTiernan A; Brant R; Jones CA; Stanczyk FZ; Terry T; Cook LS; Wang Q; Friedenreich CM
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2116-20. PubMed ID: 24019394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
